英硅智能与康哲药业达成数千万港元的中枢神经系统及自身免疫疾病领域的多个药物研发项目合作

智通财经
Feb 10

  英硅智能(03696)发布公告,集团已与康哲药业达成药物研发战略合作。透过该合作,双方将在中枢神经系统及自身免疫疾病领域的多个项目上达成一系列由AI赋能的创新药物研发合作。

  根据该合作的协议条款,双方将结合英硅智能已验证的AI平台与AI赋能创新药研发能力,以及康哲药业经验丰富的研发团队和对疾病领域的深度认知,共同推进不少于2个研发项目的合作开发。同时,英硅智能有望就每个项目获得最高达数千万港元的研发费用支持。

关注同花顺财经(ths518),获取更多机会

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10